The Dual Role of DNA Cross-linking Agents: From Genotoxicity to cGAS-STING-Mediated Immune Activation
Chemical Research in Toxicology · 17.08.2026 · 39 (8) · 1468-1482
DOI: 10.1021/acs.chemrestox.6c00132 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Chemical Research in Toxicology, online erschienen am 01.08.2026. Verfasst von Jingao Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Experimental Hematology; The Province and Ministry Co-Sponsored Collaborative Innovation Center for Medical Epigenetics; Tian…. Hauptthemen laut MEDLINE: Nucleotidyltransferases, Cross-Linking Reagents, DNA, Membrane Proteins. Die Arbeit nennt 144 Literaturangaben. Gefördert von: Tianjin Medical University, National Natural Science Foundation of China (NSFC), Natural Science Foundation of Tianjin City.
Abstract (Originalsprache)
DNA cross-linking agents remain a cornerstone of cancer chemotherapy. While their efficacy was traditionally attributed to direct genotoxicity, blocking DNA replication and transcription to induce cell death, recent evidence suggests that their therapeutic activity also involves innate immune activation. Aberrant repair of DNA lesions generates cytosolic DNA fragments, which are sensed by cyclic GMP-AMP synthase (cGAS). This activates the cGAS-STING (stimulator of interferon genes) pathway, driving the production of type I interferons and proinflammatory cytokines, thereby eliciting antitumor immunity. This review traces the molecular trajectory from DNA lesions formation to immune stimulation. We summarize the chemistry of classical and emerging DNA cross-linking agents, the replication stress they impose, and DNA damage response (DDR) generating cytosolic DNA as a trigger for innate immune activation. We then highlight key mechanistic insights into cGAS-STING signaling. Finally, we discuss therapeutic opportunities in their combinations with STING agonists for more effective immune activation. Collectively, this framework reframes DNA cross-linking agents from simple cytotoxins into in situ vaccines that harness DNA damage-driven immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Experimental Hematology; The Province and Ministry Co-Sponsored Collaborative Innovation Center for Medical Epigenetics; Tianjin Key Laboratory on Technologies Enabling Development of Clinical Th…
- Department of Nuclear Medicine, Tianjin Medical University General Hospital, Tianjin300052, China.
- State Key Laboratory of Elemento-Organic Chemistry, Nankai University, Tianjin300071, China.
ORCID-Profile: Heli Fan, Huabing Sun
Förderung
- Tianjin Medical University
- National Natural Science Foundation of China (NSFC)
- Natural Science Foundation of Tianjin City
Zitieren
APA
Li, J., Wang, L., Mao, X., Hu, D., Lu, Q., Shi, C., Wang, Y., Meng, Z., Fan, H., & Sun, H. (2026). The Dual Role of DNA Cross-linking Agents: From Genotoxicity to cGAS-STING-Mediated Immune Activation. Chemical Research in Toxicology, 39(8), 1468-1482. https://doi.org/10.1021/acs.chemrestox.6c00132
Vancouver
Li J, Wang L, Mao X, Hu D, Lu Q, Shi C, et al. The Dual Role of DNA Cross-linking Agents: From Genotoxicity to cGAS-STING-Mediated Immune Activation. Chemical Research in Toxicology. 2026;39(8):1468-1482. doi:10.1021/acs.chemrestox.6c00132
BibTeX
@article{Li2026,
author = {Li, Jingao and Wang, Luo and Mao, Xuqing and Hu, Dongmei and Lu, Qinyue and Shi, Chengyi and Wang, Yifeng and Meng, Zhaowei and Fan, Heli and Sun, Huabing},
title = {The Dual Role of DNA Cross-linking Agents: From Genotoxicity to cGAS-STING-Mediated Immune Activation},
journal = {Chemical Research in Toxicology},
year = {2026},
volume = {39},
number = {8},
pages = {1468--1482},
doi = {10.1021/acs.chemrestox.6c00132}
}
EUVIMED